- Marketwired•3 days agoCannabis Science Announces Update on Proposed DPI Inhalation Device, CBD Infused Pain Patch, and Extends Praise for President Trump's Support of Medical Cannabis, Nationwide
Cannabis Science, Inc. , a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce updates on the proposed self-medicating DPI Inhalation Device for Asthma/COPD ...
- Marketwired•10 days agoCrown Baus Capital Corp. Acquires 100-Acre Investment Participation in Cannabis Science's California and Nevada Property and Drug Development Projects
Crown Baus Capital Corp. announces the Company acquires 100-acre investment participation in the Cannabis Science, Inc. Property and Drug Development Projects spread across California and Nevada. The agreement ...
- Marketwired•20 days agoCrown Baus Team Negotiates Investment Opportunity with Cannabis Science (CBIS) for Stake in California Property Development Projects and the Nevada Cannabinoid Drug Production Facilities in Douglas County, Nevada
Crown Baus Capital Corp. , is a global acquisition-based conglomerate looking to aggressively capitalize on its key industry strengths. Mr. Raymond C. Dabney, Crown Baus President & CEO, is pleased to ...
CBIS : Summary for CANNABIS SCIENCE INC - Yahoo Finance
Cannabis Science, Inc. (CBIS)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.09 - 0.10|
|52 Week Range||0.01 - 0.14|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-10.49|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|